Hepatic Safety with SGLT2i and DPP4i SGLT2i Meta-analysis and review reports from large phase IIIII trials showed that SGLT-2i do not cause hepatotoxicity [65, 66, 69, 70]
whereas PGN exposure caused lesions with increased intestinal bacteria and enzymatic activities, evidenced by increased fecal metabolites of PGN
The companys Sync Stacks let people combine NAD+ Nasal Spray , NMN capsules, Glutathione Nasal Spray , and targeted options like NAC, B12, or melatonin nasal sprays
The biggest impact IMO will be in the self funded space - hopefully the fiduciaries of these plans will take their PBMs and plan administrators to task on reference based pricing for these drugs
MAT2A inhibition blocks the growth of MTAP-deleted cancer cells by reducing PRMT5-dependent mRNA splicing and inducing DNA damage
This graduated approach minimizes side effects while progressively increasing therapeutic benefit